Scientists probe link between lung cancer genes and deadly clots
NCT ID NCT07288632
Summary
This study aims to understand if specific genetic mutations in a patient's lung cancer make them more likely to develop dangerous blood clots, known as venous thromboembolism (VTE). Researchers will follow 500 people with advanced non-small cell lung cancer (NSCLC) for six months, comparing those with certain mutations to those without. They will regularly check blood for signs of clotting and inflammation to see if a genetic profile can help predict this serious risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emily Oliovecchio
RECRUITINGPerugia, Perugia, 06135, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.